$PAHC
PHIBRO ANIMAL HEALTH CORP

2022 Q1 Form 10-Q Financial Statement

#000141057822001141 Filed on May 04, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q4 2021 Q3
Revenue $239.6M $232.7M $214.7M
YoY Change 13.17% 12.89% 9.98%
Cost Of Revenue $168.0M $162.0M $150.0M
YoY Change 17.84% 17.52% 14.43%
Gross Profit $71.63M $70.67M $64.68M
YoY Change 3.56% 3.53% 0.87%
Gross Profit Margin 29.89% 30.37% 30.13%
Selling, General & Admin $52.43M $48.38M $50.07M
YoY Change 6.93% 0.01% 3.38%
% of Gross Profit 73.2% 68.45% 77.41%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $8.445M $8.001M $7.854M
YoY Change 6.66% -1.08% -2.26%
% of Gross Profit 11.79% 11.32% 12.14%
Operating Expenses $52.43M $48.38M $50.07M
YoY Change 6.93% 0.01% 3.38%
Operating Profit $19.19M $22.29M $14.61M
YoY Change -4.66% 12.09% -6.86%
Interest Expense $3.112M $3.102M $3.065M
YoY Change 1.01% -10.76% -1.42%
% of Operating Profit 16.21% 13.91% 20.98%
Other Income/Expense, Net
YoY Change
Pretax Income $26.83M $23.53M $9.595M
YoY Change 50.9% 46.59% -41.88%
Income Tax $9.144M $6.065M $3.061M
% Of Pretax Income 34.08% 25.78% 31.9%
Net Earnings $17.69M $17.47M $6.534M
YoY Change 45.46% 36.43% -46.89%
Net Earnings / Revenue 7.38% 7.5% 3.04%
Basic Earnings Per Share $0.44 $0.43 $0.16
Diluted Earnings Per Share $0.44 $0.43 $0.16
COMMON SHARES
Basic Shares Outstanding 40.50M 40.50M 40.50M
Diluted Shares Outstanding 40.50M 40.50M 40.50M

Balance Sheet

Concept 2022 Q1 2021 Q4 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $92.85M $95.49M $97.18M
YoY Change -0.27% -0.02% 5.63%
Cash & Equivalents $70.75M $63.39M $41.18M
Short-Term Investments $22.10M $32.10M $56.00M
Other Short-Term Assets $47.16M $39.85M $39.50M
YoY Change 28.16% -5.75% -3.69%
Inventory $249.9M $230.8M $221.3M
Prepaid Expenses
Receivables $156.6M $142.5M $140.6M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $546.5M $508.6M $498.6M
YoY Change 15.85% 6.59% 7.4%
LONG-TERM ASSETS
Property, Plant & Equipment $162.5M $154.6M $152.8M
YoY Change 8.17% 2.82% 3.79%
Goodwill $53.32M $52.68M $52.68M
YoY Change 1.22% 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments $4.063M $4.717M $4.759M
YoY Change -5.29% 1.7% 8.98%
Other Assets $86.54M $75.11M $71.78M
YoY Change 31.13% 32.15% 26.94%
Total Long-Term Assets $369.7M $340.3M $337.4M
YoY Change 10.92% 4.25% 3.73%
TOTAL ASSETS
Total Short-Term Assets $546.5M $508.6M $498.6M
Total Long-Term Assets $369.7M $340.3M $337.4M
Total Assets $916.2M $849.0M $836.0M
YoY Change 13.81% 5.64% 5.89%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $89.70M $80.66M $66.81M
YoY Change 42.82% 27.42% 6.89%
Accrued Expenses $82.41M $72.84M $74.53M
YoY Change -0.3% -10.87% -4.62%
Deferred Revenue $1.383M $1.675M $1.396M
YoY Change 4.38% -10.33% 16.72%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $15.00M $13.13M $11.25M
YoY Change -35.9% -40.07% -44.58%
Total Short-Term Liabilities $187.1M $166.6M $152.6M
YoY Change 10.78% -0.16% -5.2%
LONG-TERM LIABILITIES
Long-Term Debt $400.6M $387.3M $394.0M
YoY Change 12.28% 6.14% 4.21%
Other Long-Term Liabilities $61.51M $55.72M $56.14M
YoY Change -3.01% -4.73% -3.36%
Total Long-Term Liabilities $61.51M $55.72M $56.14M
YoY Change -3.01% -4.73% -3.36%
TOTAL LIABILITIES
Total Short-Term Liabilities $187.1M $166.6M $152.6M
Total Long-Term Liabilities $61.51M $55.72M $56.14M
Total Liabilities $649.2M $609.7M $602.7M
YoY Change 10.21% 3.28% 0.94%
SHAREHOLDERS EQUITY
Retained Earnings $245.1M $232.3M $219.7M
YoY Change 19.13% 17.05% 15.32%
Common Stock $135.8M $135.8M $135.8M
YoY Change -0.62% -0.62% -0.21%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $266.9M $239.3M $233.3M
YoY Change
Total Liabilities & Shareholders Equity $916.2M $849.0M $836.0M
YoY Change 13.81% 5.64% 5.89%

Cashflow Statement

Concept 2022 Q1 2021 Q4 2021 Q3
OPERATING ACTIVITIES
Net Income $17.69M $17.47M $6.534M
YoY Change 45.46% 36.43% -46.89%
Depreciation, Depletion And Amortization $8.445M $8.001M $7.854M
YoY Change 6.66% -1.08% -2.26%
Cash From Operating Activities $6.132M $20.12M $3.821M
YoY Change -63.13% -25.22% 125.03%
INVESTING ACTIVITIES
Capital Expenditures -$10.02M -$7.690M -$7.449M
YoY Change 33.71% 5.05% 0.39%
Acquisitions
YoY Change
Other Investing Activities $71.00K $25.26M $217.0K
YoY Change -99.59% -8519.33% 0.93%
Cash From Investing Activities -$9.944M $17.57M -$20.67M
YoY Change -200.75% -330.55% 51.57%
FINANCING ACTIVITIES
Cash Dividend Paid $4.860M
YoY Change 0.12%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 10.27M -14.58M 8.265M
YoY Change -188.87% -11.87% 27.98%
NET CHANGE
Cash From Operating Activities 6.132M 20.12M 3.821M
Cash From Investing Activities -9.944M 17.57M -20.67M
Cash From Financing Activities 10.27M -14.58M 8.265M
Net Change In Cash 6.453M 23.11M -9.037M
YoY Change -56.84% 740.51% 68.16%
FREE CASH FLOW
Cash From Operating Activities $6.132M $20.12M $3.821M
Capital Expenditures -$10.02M -$7.690M -$7.449M
Free Cash Flow $16.15M $27.81M $11.27M
YoY Change -33.06% -18.75% 23.6%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Entity Central Index Key
EntityCentralIndexKey
0001069899
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q1 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2021Q2 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2022Q1 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2021Q2 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2022Q1 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2021Q2 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
CY2021 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
CY2021 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
dei Entity Registrant Name
EntityRegistrantName
PHIBRO ANIMAL HEALTH CORP
CY2022Q1 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
CY2021Q2 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
us-gaap Derivative Maturity Dates
DerivativeMaturityDates
2023-02-28
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-36410
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
13-1840497
dei Entity Address Address Line1
EntityAddressAddressLine1
Glenpointe Centre East, 3rd Floor
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
3590000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
26833000
dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
07666-6712
dei Entity Shell Company
EntityShellCompany
false
CY2022Q1 us-gaap Revenues
Revenues
239619000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
59958000
dei City Area Code
CityAreaCode
201
dei Local Phone Number
LocalPhoneNumber
329-7300
dei Security12b Title
Security12bTitle
Class A Common Stock, $0.0001 par value per share
dei Trading Symbol
TradingSymbol
PAHC
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
17782000
dei Entity Small Business
EntitySmallBusiness
false
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Address Address Line2
EntityAddressAddressLine2
300 Frank W. Burr Boulevard, Suite 21
dei Entity Address City Or Town
EntityAddressCityOrTown
Teaneck
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
12625000
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2021Q1 us-gaap Revenues
Revenues
211729000
us-gaap Revenues
Revenues
686996000
us-gaap Revenues
Revenues
613072000
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
167993000
CY2021Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
142564000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
480020000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
411523000
CY2022Q1 us-gaap Gross Profit
GrossProfit
71626000
CY2021Q1 us-gaap Gross Profit
GrossProfit
69165000
us-gaap Gross Profit
GrossProfit
206976000
us-gaap Gross Profit
GrossProfit
201549000
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
52432000
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
49033000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
150876000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
145839000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
19194000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
20132000
us-gaap Operating Income Loss
OperatingIncomeLoss
56100000
us-gaap Operating Income Loss
OperatingIncomeLoss
55710000
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-2925000
CY2021Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-2933000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-8767000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-8957000
CY2022Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
10564000
CY2021Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
583000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
50343000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9144000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5621000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18270000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13079000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
17689000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
12161000
us-gaap Net Income Loss
NetIncomeLoss
41688000
us-gaap Net Income Loss
NetIncomeLoss
37264000
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.44
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.30
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.92
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.44
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.30
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.92
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40504000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1309000
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40483000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40504000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40463000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40504000
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40504000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40504000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40504000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
17689000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
12161000
us-gaap Net Income Loss
NetIncomeLoss
41688000
us-gaap Net Income Loss
NetIncomeLoss
37264000
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent
14958000
CY2021Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent
5749000
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent
19739000
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent
10567000
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
3514000
CY2021Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-9122000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-13761000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-4345000
CY2022Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPortionAttributableToParent
-120000
CY2021Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPortionAttributableToParent
-144000
us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPortionAttributableToParent
-354000
us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPortionAttributableToParent
-416000
CY2022Q1 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
3770000
CY2021Q1 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
1473000
us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
5023000
us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
2745000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
14822000
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-4702000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
3893000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
32511000
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
7459000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
42997000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
41157000
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
70748000
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
50212000
CY2022Q1 us-gaap Short Term Investments
ShortTermInvestments
22100000
CY2021Q2 us-gaap Short Term Investments
ShortTermInvestments
43000000
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
156561000
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
146852000
CY2022Q1 us-gaap Inventory Net
InventoryNet
249911000
CY2021Q2 us-gaap Inventory Net
InventoryNet
216312000
CY2021Q2 us-gaap Assets Current
AssetsCurrent
498909000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
162455000
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Other Assets Current
OtherAssetsCurrent
47157000
CY2021Q2 us-gaap Other Assets Current
OtherAssetsCurrent
42533000
CY2022Q1 us-gaap Assets Current
AssetsCurrent
546477000
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
154706000
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
67384000
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
62282000
CY2022Q1 us-gaap Goodwill
Goodwill
53321000
CY2021Q2 us-gaap Goodwill
Goodwill
52679000
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
86544000
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
72749000
CY2022Q1 us-gaap Assets
Assets
916181000
CY2021Q2 us-gaap Assets
Assets
841325000
CY2022Q1 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
15000000
CY2021Q2 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
9375000
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
89696000
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
68362000
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
82406000
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
86379000
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
187102000
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
164116000
CY2022Q1 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
124000000
CY2021Q2 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
95000000
CY2022Q1 us-gaap Long Term Loans Payable
LongTermLoansPayable
276621000
CY2021Q2 us-gaap Long Term Loans Payable
LongTermLoansPayable
287710000
CY2022Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
61513000
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
55970000
CY2022Q1 us-gaap Liabilities
Liabilities
649236000
CY2021Q2 us-gaap Liabilities
Liabilities
602796000
CY2022Q1 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
4000
CY2021Q2 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
4000
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
16000000
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
16000000
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
135803000
CY2021Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
135803000
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
245122000
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
218015000
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-113984000
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-115293000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
266945000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
238529000
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
916181000
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
841325000
us-gaap Net Income Loss
NetIncomeLoss
41688000
us-gaap Net Income Loss
NetIncomeLoss
37264000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
24300000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
24042000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
442000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
662000
us-gaap Share Based Compensation
ShareBasedCompensation
0
us-gaap Share Based Compensation
ShareBasedCompensation
1129000
pahc Acquisition Related Items
AcquisitionRelatedItems
78000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-120000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
18000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
13492000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
7293000
us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
1203000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-284000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-389000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
10815000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
8410000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
30548000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
8091000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1879000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-3746000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
2364000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
1019000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
19961000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-751000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
3743000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
3550000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
30075000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
45236000
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
54100000
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
50000000
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
75000000
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
61000000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
25154000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
22226000
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
10786000
us-gaap Proceeds From Sale Of Investment Projects
ProceedsFromSaleOfInvestmentProjects
1353000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-645000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
164000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-13042000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11390000
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
215000000
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
135000000
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
186000000
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
128000000
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-5625000
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-14063000
us-gaap Payments Of Dividends
PaymentsOfDividends
14581000
us-gaap Payments Of Dividends
PaymentsOfDividends
14569000
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
4840000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3954000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-21632000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-451000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
546000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
20536000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
12760000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
50212000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
36343000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
70748000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
49103000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
238529000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-364000
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.12
CY2021Q3 us-gaap Dividends
Dividends
4860000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
233305000
CY2021Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
10850000
CY2021Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.12
CY2021Q4 us-gaap Dividends
Dividends
4861000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
239294000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
32511000
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.12
CY2022Q1 us-gaap Dividends
Dividends
4860000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
266945000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
188204000
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
8497000
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.12
CY2020Q3 us-gaap Dividends
Dividends
4854000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
565000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
192412000
CY2020Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
25201000
CY2020Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.12
CY2020Q4 us-gaap Dividends
Dividends
4855000
CY2020Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
564000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
213322000
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
7459000
CY2021Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.12
CY2021Q1 us-gaap Dividends
Dividends
4860000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
215921000
us-gaap Nature Of Operations
NatureOfOperations
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">1.  Description of Business</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Phibro Animal Health Corporation (“Phibro” or “PAHC”) and its subsidiaries (together, the “Company”) is a diversified global developer, manufacturer and marketer of a broad range of animal health and mineral nutrition products for food animals including poultry, dairy and beef cattle, swine, and aquaculture. The Company is also a manufacturer and marketer of performance products for use in the personal care, industrial chemical and chemical catalyst industries. Unless otherwise indicated or the context requires otherwise, references in this report to “we,” “our,” “us,” and similar expressions refer to Phibro and its subsidiaries.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The unaudited consolidated financial information for the three and nine months ended March 31, 2022 and 2021, is presented on the same basis as the financial statements included in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2021 (the “Annual Report”), filed with the Securities and Exchange Commission on August 25, 2021 (File no. 001-36410). In the opinion of management, these financial statements include all adjustments necessary for a fair statement of the financial position, results of operations and cash flows of the Company for the interim periods, and the adjustments are of a normal and recurring nature. The financial results for any interim period are not necessarily indicative of the results for the full year. The consolidated balance sheet information as of June 30, 2021, was derived from the audited consolidated financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America (“GAAP”). The unaudited consolidated financial information should be read in conjunction with the consolidated financial statements and notes thereto included in the Annual Report.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses and the disclosure of contingent assets and liabilities. Actual results could differ from those estimates. The full extent to which the COVID-19 pandemic will directly or indirectly impact our business, results of operations and financial condition will depend on future developments that are uncertain. Although vaccines are available, distribution efforts vary widely country-by-country and state-by-state. New information may continue to emerge concerning COVID-19, and the actions required to contain or treat it may affect the duration and severity of the pandemic. The pandemic may have significant economic impacts on customers, suppliers and markets. The pandemic may affect our future revenues, expenses, reserves and allowances, manufacturing operations and employee-related costs. Our financial statements include estimates of the effects of COVID-19 and there may be changes to those estimates in future periods. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The consolidated financial statements include the accounts of Phibro and its consolidated subsidiaries. Intercompany balances and transactions have been eliminated from the consolidated financial statements. The decision to consolidate an entity requires consideration of majority voting interests, as well as effective control over the entity.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p>
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
17689000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
12161000
us-gaap Net Income Loss
NetIncomeLoss
41688000
us-gaap Net Income Loss
NetIncomeLoss
37264000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40504000
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40483000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40504000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40463000
CY2021Q1 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
21000
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
41000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40504000
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40504000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40504000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40504000
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.44
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.30
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.92
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.44
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.30
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.92
CY2022Q1 pahc Revenue From External Customers By Geographic Areas
RevenueFromExternalCustomersByGeographicAreas
239619000
CY2021Q1 pahc Revenue From External Customers By Geographic Areas
RevenueFromExternalCustomersByGeographicAreas
211729000
pahc Revenue From External Customers By Geographic Areas
RevenueFromExternalCustomersByGeographicAreas
686996000
pahc Revenue From External Customers By Geographic Areas
RevenueFromExternalCustomersByGeographicAreas
613072000
CY2022Q1 pahc Revenue From External Customers By Geographic Areas
RevenueFromExternalCustomersByGeographicAreas
239619000
CY2021Q1 pahc Revenue From External Customers By Geographic Areas
RevenueFromExternalCustomersByGeographicAreas
211729000
pahc Revenue From External Customers By Geographic Areas
RevenueFromExternalCustomersByGeographicAreas
686996000
pahc Revenue From External Customers By Geographic Areas
RevenueFromExternalCustomersByGeographicAreas
613072000
CY2022Q1 us-gaap Deferred Revenue
DeferredRevenue
2697000
CY2021Q2 us-gaap Deferred Revenue
DeferredRevenue
3674000
CY2022Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1383000
CY2021Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1560000
CY2022Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
147000
CY2021Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
221000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
442000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
662000
CY2022Q1 us-gaap Interest Expense Other
InterestExpenseOther
67000
CY2021Q1 us-gaap Interest Expense Other
InterestExpenseOther
65000
us-gaap Interest Expense Other
InterestExpenseOther
156000
us-gaap Interest Expense Other
InterestExpenseOther
191000
CY2022Q1 us-gaap Interest Expense
InterestExpense
3112000
CY2021Q1 us-gaap Interest Expense
InterestExpense
3081000
us-gaap Interest Expense
InterestExpense
9279000
us-gaap Interest Expense
InterestExpense
9666000
CY2022Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
187000
CY2021Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
148000
us-gaap Interest And Other Income
InterestAndOtherIncome
512000
us-gaap Interest And Other Income
InterestAndOtherIncome
709000
CY2022Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-2925000
CY2021Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-2933000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-8767000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-8957000
CY2022Q1 us-gaap Depreciation
Depreciation
6214000
CY2021Q1 us-gaap Depreciation
Depreciation
5763000
us-gaap Depreciation
Depreciation
17792000
us-gaap Depreciation
Depreciation
17479000
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2231000
CY2021Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2155000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6508000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6563000
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8445000
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7918000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
24300000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
24042000
CY2022Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
85255000
CY2021Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
59775000
CY2022Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
12900000
CY2021Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
12738000
CY2022Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
151756000
CY2021Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
143799000
CY2022Q1 us-gaap Inventory Net
InventoryNet
249911000
CY2021Q2 us-gaap Inventory Net
InventoryNet
216312000
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
38691000
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
32962000
CY2022Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
4097000
CY2021Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
9861000
CY2022Q1 us-gaap Deposits Assets
DepositsAssets
6293000
CY2021Q2 us-gaap Deposits Assets
DepositsAssets
5663000
CY2022Q1 pahc Insurance Investment
InsuranceInvestment
6054000
CY2021Q2 pahc Insurance Investment
InsuranceInvestment
5964000
CY2022Q1 us-gaap Equity Method Investments
EquityMethodInvestments
4063000
CY2021Q2 us-gaap Equity Method Investments
EquityMethodInvestments
4141000
CY2022Q1 us-gaap Derivative Instruments And Hedges
DerivativeInstrumentsAndHedges
14560000
CY2021Q2 us-gaap Derivative Instruments And Hedges
DerivativeInstrumentsAndHedges
2696000
CY2022Q1 pahc Pension And Other Postretirement And Postemployment Benefit Plans Assets Noncurrent
PensionAndOtherPostretirementAndPostemploymentBenefitPlansAssetsNoncurrent
2482000
CY2021Q2 pahc Pension And Other Postretirement And Postemployment Benefit Plans Assets Noncurrent
PensionAndOtherPostretirementAndPostemploymentBenefitPlansAssetsNoncurrent
1184000
CY2022Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1530000
CY2021Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1811000
CY2022Q1 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
8774000
CY2021Q2 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
8467000
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
86544000
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
72749000
us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
10833000
CY2021Q4 us-gaap Goodwill
Goodwill
52679000
CY2020Q2 us-gaap Goodwill
Goodwill
52679000
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
595000
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
47000
CY2022Q1 us-gaap Goodwill
Goodwill
53321000
CY2021Q2 us-gaap Goodwill
Goodwill
52679000
CY2022Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
30601000
CY2021Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
35375000
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6431000
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6618000
CY2022Q1 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
6528000
CY2021Q2 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
6312000
CY2022Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
6057000
CY2021Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
4380000
CY2022Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
7890000
CY2021Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
6107000
CY2022Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
391000
CY2021Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
3486000
CY2022Q1 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
0
CY2021Q2 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
4840000
CY2022Q1 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
0
CY2021Q2 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
735000
CY2022Q1 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
1179000
CY2021Q2 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
1176000
CY2022Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
23329000
CY2021Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
17350000
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
82406000
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
86379000
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
33632000
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
28003000
CY2022Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
8848000
CY2021Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
6646000
CY2022Q1 us-gaap Other Postretirement Defined Benefit Plan Liabilities Noncurrent
OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent
8487000
CY2021Q2 us-gaap Other Postretirement Defined Benefit Plan Liabilities Noncurrent
OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent
8382000
CY2022Q1 pahc International Retirement Plans
InternationalRetirementPlans
4821000
CY2021Q2 pahc International Retirement Plans
InternationalRetirementPlans
5345000
CY2022Q1 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
5725000
CY2021Q2 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
7594000
CY2022Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
61513000
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
55970000
CY2022Q1 us-gaap Aoci Loss Cash Flow Hedge Cumulative Gain Loss After Tax
AociLossCashFlowHedgeCumulativeGainLossAfterTax
18949000
CY2021Q2 us-gaap Aoci Loss Cash Flow Hedge Cumulative Gain Loss After Tax
AociLossCashFlowHedgeCumulativeGainLossAfterTax
-790000
CY2022Q1 pahc Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Before Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentBeforeTax
-113856000
CY2021Q2 pahc Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Before Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentBeforeTax
-100095000
CY2022Q1 pahc Accumulated Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Before Tax
AccumulatedOtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeTax
19619000
CY2021Q2 pahc Accumulated Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Before Tax
AccumulatedOtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeTax
19973000
CY2022Q1 pahc Accumulated Other Comprehensive Income Loss Income Tax Provision Benefit On Derivative Instruments
AccumulatedOtherComprehensiveIncomeLossIncomeTaxProvisionBenefitOnDerivativeInstruments
-4838000
CY2021Q2 pahc Accumulated Other Comprehensive Income Loss Income Tax Provision Benefit On Derivative Instruments
AccumulatedOtherComprehensiveIncomeLossIncomeTaxProvisionBenefitOnDerivativeInstruments
97000
CY2022Q1 pahc Income Tax Provision Benefit On Long Term Intercompany Loans
IncomeTaxProvisionBenefitOnLongTermIntercompanyLoans
8166000
CY2021Q2 pahc Income Tax Provision Benefit On Long Term Intercompany Loans
IncomeTaxProvisionBenefitOnLongTermIntercompanyLoans
8166000
CY2022Q1 pahc Accumulated Other Comprehensive Income Loss Income Tax Provision Benefit On Pension Gains Losses
AccumulatedOtherComprehensiveIncomeLossIncomeTaxProvisionBenefitOnPensionGainsLosses
-2786000
CY2021Q2 pahc Accumulated Other Comprehensive Income Loss Income Tax Provision Benefit On Pension Gains Losses
AccumulatedOtherComprehensiveIncomeLossIncomeTaxProvisionBenefitOnPensionGainsLosses
-2698000
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-113984000
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-115293000
us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
1203000
CY2022Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
292500000
CY2021Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
298125000
CY2022Q1 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
879000
CY2021Q2 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
1040000
CY2022Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
291621000
CY2021Q2 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
297085000
CY2022Q1 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
15000000
CY2021Q2 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
9375000
CY2022Q1 us-gaap Long Term Loans Payable
LongTermLoansPayable
276621000
CY2021Q2 us-gaap Long Term Loans Payable
LongTermLoansPayable
287710000
CY2022Q1 pahc Acquisition Related Cost Of Goods Sold
AcquisitionRelatedCostOfGoodsSold
78000
CY2021Q1 us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
0
pahc Number Of Potentially Responsible Parties
NumberOfPotentiallyResponsibleParties
140
CY2022Q3 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
300000000
CY2022Q3 us-gaap Derivative Notional Amount
DerivativeNotionalAmount
300000000
CY2022Q1 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2021Q2 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
4840000
CY2021Q1 pahc Acquisition Related Cost Of Goods Sold
AcquisitionRelatedCostOfGoodsSold
0
pahc Acquisition Related Cost Of Goods Sold
AcquisitionRelatedCostOfGoodsSold
78000
CY2022Q1 pahc Acquisition Related Transaction Costs
AcquisitionRelatedTransactionCosts
279000
CY2021Q1 pahc Acquisition Related Transaction Costs
AcquisitionRelatedTransactionCosts
0
pahc Acquisition Related Transaction Costs
AcquisitionRelatedTransactionCosts
279000
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
0
us-gaap Share Based Compensation
ShareBasedCompensation
1129000
CY2022Q1 pahc Segment Assets
SegmentAssets
916181000
CY2021Q2 pahc Segment Assets
SegmentAssets
841325000

Files In Submission

Name View Source Status
0001410578-22-001141-index-headers.html Edgar Link pending
0001410578-22-001141-index.html Edgar Link pending
0001410578-22-001141.txt Edgar Link pending
0001410578-22-001141-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pahc-20220331.xsd Edgar Link pending
pahc-20220331x10q.htm Edgar Link pending
pahc-20220331x10q_htm.xml Edgar Link completed
pahc-20220331xex31d1.htm Edgar Link pending
pahc-20220331xex31d2.htm Edgar Link pending
pahc-20220331xex32d1.htm Edgar Link pending
pahc-20220331xex32d2.htm Edgar Link pending
pahc-20220331_cal.xml Edgar Link unprocessable
pahc-20220331_def.xml Edgar Link unprocessable
pahc-20220331_lab.xml Edgar Link unprocessable
pahc-20220331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending